Why is Kobo Biotech falling/rising?

As of 23-Sep, Kobo Biotech Ltd's stock price is currently at 2.25, reflecting a decrease of 0.07, or 3.02%. The stock has underperformed its sector by 2.46% today and has experienced a trend reversal, falling after two consecutive days of gains. Additionally, Kobo Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 3.02%, and it has seen a significant drop of 19.35% over the past year. While there has been a notable increase in delivery volume, rising by 97.28% against the 5-day average, no specific positive or negative factors have been provided to explain the stock's recent movements.
In the broader market context, Kobo Biotech's recent performance contrasts sharply with the Sensex, which has only declined by 0.34% over the past week. This underperformance suggests that the stock is not only struggling in its sector but also lagging behind the overall market trends. The year-to-date performance of the Sensex shows a gain of 5.07%, while Kobo Biotech's longer-term returns indicate a significant decline, particularly over the last three and five years, where it has fallen by 59.24% and 71.84%, respectively. This stark difference highlights the challenges Kobo Biotech faces in regaining investor confidence and aligning with broader market recovery trends.